返回
Optimization and clinical validation of a pathogen detection microarray
DOI:10.1186/gb-2007-8-5-r93.png)
摘要
En 中文
DNA microarrays used as genomic sensors have great potential in clinical diagnostics. Biases inherent in random PCR-amplification, cross-hybridization effects, and inadequate microarray analysis, however, limit detection sensitivity and specificity. Here, we have studied the relationships between viral amplification efficiency, hybridization signal, and target-probe annealing specificity using a customized microarray platform. Novel features of this platform include the development of a robust algorithm that accurately predicts PCR bias during DNA amplification and can be used to improve PCR primer design, as well as a powerful statistical concept for inferring pathogen identity from probe recognition signatures. Compared to real-time PCR, the microarray platform identified pathogens with 94% accuracy (76% sensitivity and 100% specificity) in a panel of 36 patient specimens. Our findings show that microarrays can be used for the robust and accurate diagnosis of pathogens, and further substantiate the use of microarray technology in clinical diagnostics.
Keyword:
RESPIRATORY SYNCYTIAL VIRUS
NUCLEIC-ACID ANALYSIS
SECONDARY STRUCTURE
RT-PCR
ARRAYS
HYBRIDIZATION
INFECTIONS
AMPLIFICATION
QUANTITATION
DIAGNOSTICS
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
G
IF:
9.4
论文数:
6.4K
被引数:
7.3W
机构
暂无机构信息
引用论文
Selection of optimal oligonucleotide probes for microarrays using multiple criteria, global alignment and parameter estimation
NUCLEIC ACIDS RESEARCH
IF13.1
Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays
GENOME RESEARCH
IF5.5
Secondary structure in the target as a confounding factor in synthetic oligomer microarray design
BMC GENOMICS
IF3.7

